Back to Trades
Martini Jeffrey S
Chief Scientific OfficerCIK 0001914560
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 1
- Buy transactions
- 0
- Sell transactions
- 0
- Companies
- 1
- Active
- 2026
Martini Jeffrey S, Chief Scientific Officer, has filed 1 SEC report (2026), all concentrated in PALVELLA THERAPEUTICS, INC. (PVLA), totaling $4.9M in disclosed volume. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
1 loaded
| Feb 9 | PVLA PALVELLA THERAPEUTICS, INC. | Martini Jeffrey S | Chief Scientific Officer | Award | $4.9M |
1 filing